Thu, January 27, 2022
Wed, January 26, 2022
Tue, January 25, 2022
Mon, January 24, 2022
Sun, January 23, 2022
Sat, January 22, 2022
Fri, January 21, 2022
Thu, January 20, 2022
Wed, January 19, 2022

Marc Goodman Maintained (BIIB) at Buy with Decreased Target to $300 on, Jan 24th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-300-on-jan-24th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Marc Goodman of SVB Leerink, Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $325 to $300 on, Jan 24th, 2022.

Marc has made no other calls on BIIB in the last 4 months.



There are 20 other peers that have a rating on BIIB. Out of the 20 peers that are also analyzing BIIB, 12 agree with Marc's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $244 on, Thursday, January 20th, 2022
  • Yatin Suneja of "Guggenheim" Downgraded from Strong Buy to Hold and Decreased Target to $202 on, Thursday, January 13th, 2022
  • Salim Syed of "Mizuho" Maintained at Hold with Decreased Target to $207 on, Wednesday, January 12th, 2022
  • Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $195 on, Wednesday, January 12th, 2022
  • Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $216 on, Wednesday, January 12th, 2022
  • Geoff Meacham of "B of A Securities" Maintained at Hold with Decreased Target to $275 on, Thursday, December 23rd, 2021
  • Brian Skorney of "Baird" Maintained at Hold with Decreased Target to $258 on, Tuesday, December 21st, 2021
  • Cory Kasimov of "JP Morgan" Maintained at Hold with Decreased Target to $276 on, Tuesday, December 21st, 2021
  • Mohit Bansal of "Wells Fargo" Initiated at Hold and Held Target at $250 on, Thursday, December 9th, 2021
  • Salveen Richter of "Goldman Sachs" Initiated at Hold and Held Target at $271 on, Monday, December 6th, 2021
  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $277 on, Friday, November 19th, 2021
  • Alethia Young of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $327 on, Friday, October 15th, 2021


These are the ratings of the 8 analyists that currently disagree with Marc


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $270 on, Tuesday, January 18th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $360 on, Tuesday, January 18th, 2022
  • Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $292 on, Wednesday, January 12th, 2022
  • Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $350 on, Wednesday, December 22nd, 2021
  • Evan Seigerman of "BMO Capital" Initiated at Buy and Held Target at $315 on, Friday, November 19th, 2021
  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Decreased Target to $375 on, Thursday, October 21st, 2021
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $344 on, Friday, October 15th, 2021
  • Michael Yee of "Jefferies" Maintained at Strong Buy with Decreased Target to $400 on, Friday, October 8th, 2021

Publication Contributing Sources